Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome

Nephrology

Volumn 15, Issue 3, 2010, Pages 321-326

  Fukuda, Akihiro ^a   Fujimoto, Shouichi ^a   Iwatsubo, Shuji ^a   Kawachi, Hiroshi ^b   Kitamura, Kazuo ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Nephrotic syndrome; Podocyte; Proteinuria; Rennin angiotensin aldos terone system; Slit diaphragm

Indexed keywords

ALBUMIN; CHOLESTEROL; EPLERENONE; LOSARTAN; NEPHRIN; NITROGEN; PODOCALYXIN; PODOCIN; POTASSIUM; PUROMYCIN AMINONUCLEOSIDE; UREA;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; GLOMERULUS; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEINURIA; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPRAGUE DAWLEY RAT; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION;

ALDOSTERONE ANTAGONISTS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LOSARTAN; MALE; MEMBRANE PROTEINS; NEPHROSIS, LIPOID; PODOCYTES; PROTEINURIA; PUROMYCIN AMINONUCLEOSIDE; RATS; RATS, SPRAGUE-DAWLEY; SIALOGLYCOPROTEINS; SPIRONOLACTONE; TIME FACTORS;

EID: 77950515108     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2009.01256.x     Document Type: Article

References (30)

1. Kawachi H, Shimizu F. Molecular composition and function of the slit diaphragm: Nephrin, the molecular responsible for proteinuria. Clin. Exp. Nephron. 2000 4 : 161 172.
2. Roselli S, Heidet L, Sich M et al. Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Mol. Cell. Biol. 2004 24 : 550 560.
3. Suzuki K, Han GD, Miyauchi N et al. Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall. Am. J. Pathol. 2007 170 : 1841 1853.
4. Nagase M, Shibata S, Yoshida S et al. Podocyte injury underlies the glomerulopathy of Dahl Salt-Hypertensive rats and is reversed by aldosterone blocker. Hypertension 2006 47 : 1084 1093.
5. Nakhoul F, Khankin E, Yaccob A et al. Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome. Am. J. Physiol. 2008 294 : 628 637.
6. Shibata S, Nagase M, Yoshida S, Kawachi H, Fujita T. Podocyte as the target for aldosterone: Roles of oxidative stress and Sgk1. Hypertension 2007 49 : 355 364.
7. Jia J, Ding G, Zhu J et al. Angiotensin II infusion induces nephrin expression changes and podocyte apoptosis. Am. J. Nephrol. 2008 28 : 500 507.
8. Kawachi H, Koike H, Kurihara H et al. Cloning of rat nephrin: Expression in developing glomeruli and in proteinuric states. Kidney Int. 2000 57 : 1949 1961.
9. Piecha G, Koleganova N, Gross ML et al. Regression of glomerulosclerosis in subtotally nephrectomized rats-effects of monotherpy with losartan, spironolactone, and their combination. Am. J. Physiol. Renal. Physiol. 2008 295 : F137 F144.
10. Trachtman H, Zaviliwitz B, Bennett B, Goldsmith DI. The effect of captopril on urinary protein excretion in puromycin aminonucleoside nephrosis in rats. Pediatr. Res. 1985 19 : 828 834.
11. Yayama K, Kawao M, Tujii H, Itoh N, Okamoto H. Dup 753 prevents the development of puromycin aminonucleoside-induced nephrosis. Eur. J. Pharmacol. 1993 236 : 337 338.
12. Kawachi H, Miyauchi N, Suzuki K et al. Role of podocyte slit diaphragm as a filtration barrier. Nephrology (Carlton) 2006 11 : 274 281.
13. Jones N, Blasutig IM, Eremina V et al. Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes. Nature 2006 440 : 818 823.
14. Uchida K, Suzuki K, Iwamoto M et al. Decreased tyrocine phosphorylation of nephrin in rat and human nephrosis. Kidney Int. 2008 73 : 926 932.
15. Kang YS, Ko GJ, Lee MH et al. Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats. Nephrol. Dial. Transplant. 2009 24 : 73 84.
16. Kramer AB, van del Meulen EF, Hamming I, van Goor H, Navis G. Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis. Kidney Int. 2007 71 : 417 424.
17. Mann JF, Schmieder RE, McQueen M et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): A multicentre, randomized, double-blind, controlled trial. Lancet 2008 372 : 547 553.
18. Epstein M. Re-examining RAS-blocking treatment regimens for abrogating progression of chronic kidney disease. Nat. Clin. Pract. Nephrol. 2009 5 : 12 13.
19. Epstein M. Aldosterone blockade: An emerging strategy for abrogating progressive renal disease. Am. J. Med. 2006 119 : 912 919.
20. Liebau M, Lang D, Böhm J et al. Functional expression of the rennin-angiotensin system in human podocytes. Am. J. Physiol. 2006 290 : F710 F719.
21. Hoffmann S, Podlich D, Hähnel B, Kriz W, Gretz N. Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J. Am. Soc. Nephrol. 2004 15 : 1475 1487.
22. Nagase M, Matsui H, Shibata S, Gotoda T, Fujita T. Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: Role of oxidative stress. Hypertension 2007 50 : 877 883.
23. Durvasula RV, Petermann AT, Hiromura K et al. Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int. 2004 65 : 30 9.
24. Gwinner W, Landmesser U, Brandes RP et al. Reactive oxygen species and antioxidant defense in puromycin aminonucleoside glomerulopathy. J. Am. Soc. Nephrol. 1997 8 : 1722 1731.
25. Wiggins RC. The spectrum of podocytopathies: A unifying view of glomerular disease. Kidney Int. 2007 71 : 1205 1214.
26. Whaley-Connell AT, Chowdhury NA, Hayden MR et al. Oxidative stress and glomerular filtration barrier injury: Role of the renin-angiotensin system in the Ren2 transgenic rat. Am. J. Physiol. Renal. Physiol. 2006 291 : F1308 F1314.
27. Nishiyama A, Yao L, Nagai Y et al. Possible contribution of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension 2004 43 : 841 848.
28. Nagase M, Fujita T. Aldosterone and glomerular podocyte injury. Clin. Exp. Nephrol. 2008 12 : 233 242.
29. Yagi S, Morita T, Katayama S. Combined treatment with an AT1 receptor blocker and angiotensin converting enzyme inhibitor has an additive effect on inhibiting neointima formation via improvement of nitric oxide production and suppression of oxidative stress. Hypertens. Res. 2004 27 : 129 135.
30. Someya T, Kaneko K, Yamada T, Yamashiro Y. Effect of a novel free radical scavenger, edaravone, on puromycin aminonucleoside induced nephrosis in rats. Pediatr. Nephrol. 2005 20 : 1430 1434.